@article{fa6276aea81141fc9faf337ea41c0e6d,
title = "The approval of sintilimab for classical hodgkin's lymphoma: Views and perspectives of anti-pd-1/pd-l1 antibodies in china",
keywords = "Checkpoint inhibitor, Checkpoint inhibitor, Classic Hodgkin's lymphoma, PD-1 antibody, Sintilimab",
author = "Mi Deng",
year = "2019",
doi = "10.1093/abt/tbz005",
language = "English (US)",
volume = "2",
pages = "54--55",
journal = "Antibody Therapeutics",
issn = "2516-4236",
publisher = "Oxford University Press",
number = "2",
}